Search Results - "FIERABRACCI, P"

Refine Results
  1. 1
  2. 2

    Weight loss effect of liraglutide in real-life: the experience of a single Italian obesity center by Ferrari, F., Fierabracci, P., Salvetti, G., Jaccheri, R., Vitti, J., Scartabelli, G., Meola, A., Magno, S., Ceccarini, G., Santini, F.

    Published in Journal of endocrinological investigation (01-12-2020)
    “…Purpose Several randomized controlled clinical trials (RCCTs) have shown that the use of Liraglutide (L) in addition to diet and exercise in patients with…”
    Get full text
    Journal Article
  3. 3

    Possible added value of thyroglobulin antibody (TgAb) testing in the evaluation of thyroidal status of subjects with overweight or obesity by Fierabracci, P., Basolo, A., Scartabelli, G., Bechi Genzano, S., Salvetti, G., Sotgia, G., Rotondi, M., Chiovato, L., Ceccarini, G., Santini, F.

    Published in Journal of endocrinological investigation (01-11-2022)
    “…Purpose An increase in serum TSH concentrations in the absence of thyroid disease, named isolated hyperthyrotropinemia, is frequently observed in subjects with…”
    Get full text
    Journal Article
  4. 4

    Histological pattern and gene expression profiling of thyroid tissue in subjects with obesity by Basolo, A., Poma, A. M., Giannini, R., Ceccarini, G., Pelosini, C., Fierabracci, P., Castany, M. U., Bechi Genzano, S., Ambrosini, C. E., Materazzi, G., Chiovato, L., Basolo, F., Santini, F., Torregrossa, L.

    Published in Journal of endocrinological investigation (01-02-2022)
    “…Purpose Subjects with obesity may exhibit an increase in serum TSH concentrations. Several mechanisms have been proposed to explain this association, including…”
    Get full text
    Journal Article
  5. 5

    LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia by Magno, S, Ceccarini, G, Pelosini, C, Jaccheri, R, Vitti, J, Fierabracci, P, Salvetti, G, Airoldi, G, Minale, M, Saponati, G, Santini, F

    Published in Lipids in health and disease (24-05-2018)
    “…Hypercholesterolemia is a major risk factor for cardiovascular disorders and requires specific intervention through an adequate lifestyle (diet and physical…”
    Get full text
    Journal Article
  6. 6

    Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery by Giustarini, E, Pinchera, A, Fierabracci, P, Roncella, M, Fustaino, L, Mammoli, C, Giani, C

    Published in European journal of endocrinology (01-05-2006)
    “…Background: Previous studies have demonstrated a high prevalence of thyroperoxidase antibodies (TPOAb) and autoimmune hypothyroidism in breast cancer (BC)…”
    Get full text
    Journal Article
  7. 7

    Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding by Giannetti, M, Piaggi, P, Ceccarini, G, Mazzeo, S, Querci, G, Fierabracci, P, Salvetti, G, Galli, G, Ricco, I, Martinelli, S, Di Salvo, C, Anselmino, M, Landi, A, Vitti, P, Pinchera, A, Santini, F

    Published in International Journal of Obesity (01-03-2012)
    “…BACKGROUND: Nonalcoholic fatty liver disease is a common finding in obese subjects. Increasing evidence has been provided suggesting that it represents the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Frequency of the GPR7 Tyr135Phe allelic variant in lean and obese subjects by Pelosini, C., Maffei, M., Ceccarini, G., Marchi, M., Marsili, A., Galli, G., Scartabelli, G., Tamberi, A., Latrofa, F., Fierabracci, P., Vitti, P., Pinchera, A., Santini, F.

    Published in Journal of endocrinological investigation (01-10-2013)
    “…Background: GPR7 , the endogenous coupled receptor for neuropeptide B and neuropeptide W, is expressed in several regions of the central nervous system, which…”
    Get full text
    Journal Article
  10. 10

    Exploring the concept of eating dyscontrol in severely obese patients candidate to bariatric surgery by Calderone, A., Mauri, M., Calabrò, P. F., Piaggi, P., Ceccarini, G., Lippi, C., Fierabracci, P., Landi, A., Vitti, P., Santini, F.

    Published in Clinical obesity (01-02-2015)
    “…Summary Eating dyscontrol constitutes a potential negative predictor for the outcome of treatment strategies for obese patients. The aim of this study was to…”
    Get full text
    Journal Article
  11. 11

    Association between breast cancer and autoimmune thyroid disorders: no increase of lymphocytic infiltrates in breast malignant tissues by Fierabracci, P, Pinchera, A, Campani, D, Pollina, L E, Giustarini, E, Giani, C

    Published in Journal of endocrinological investigation (01-03-2006)
    “…An association between thyroid autoimmunity and breast cancer (BC) has been consistently reported, but the cause of this association is still unknown. The role…”
    Get full text
    Journal Article
  12. 12

    Ultrasonographic evaluation of liver volume and the metabolic syndrome in obese women by Santini, F, Giannetti, M, Mazzeo, S, Fierabracci, P, Scartabelli, G, Marsili, A, Valeriano, R, Pucci, A, Anselmino, M, Zampa, V, Vitti, P, Pinchera, A

    Published in Journal of endocrinological investigation (01-02-2007)
    “…Non-alcoholic fatty liver disease is a common finding in obese subjects, and increasing evidence has been provided suggesting that it represents the hepatic…”
    Get full text
    Journal Article
  13. 13

    Absence of interference of serum IgGs from patients with breast cancer and thyroid autoimmunity on the function of human iodide symporter gene stably transfected in CHO cells by Fierabracci, P, Pinchera, A, Tonacchera, M, Agretti, P, De Marco, G, Albertini, S, Conforti, G, Seregni, E, Agresti, R, Grasso, L, Giani, C

    Published in Journal of endocrinological investigation (01-10-2004)
    “…The cause of the association between breast cancer (BC) and thyroid autoimmunity is still unknown. Na+/I- symporter (NIS) is highly expressed in BC cells, and…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Insulin-like growth factor II (IGF-II) immunohistochemistry in breast cancer: relationship with the most important morphological and biochemical prognostic parameters by GIANI, C, CAMPANI, D, RASMUSSEN, A, FIERABRACCI, P, MICCOLI, P, BEVILACQUA, G, PINCHERA, A, CULLEN, K. J

    “…Recent in situ hybridization experiments have shown a high content of IGF-II mRNA in breast cancer stroma. The aim of this study was to examine the…”
    Get full text
    Journal Article
  17. 17

    Relevance of estrogen and progesterone receptors enzyme immunoassay in malignant, benign and surrounding normal thyroid tissue by BONACCI, R, PINCHERA, A, FIERABRACCI, P, GIGLIOTTI, A, GRASSO, L, GIANI, C

    Published in Journal of endocrinological investigation (01-03-1996)
    “…Several authors have demonstrated the presence of estrogen receptors (ER) and progesterone receptors (PR) in thyroid tissue, generally using dextran coated…”
    Get full text
    Journal Article
  18. 18

    Stromal IGF-II messenger RNA in breast cancer : Relationship with progesterone receptor expressed by malignant epithelial cells by GIANI, C, PINCHERA, A, RASMUSSEN, A, FIERABRACCI, P, BONACCI, R, CAMPANI, D, BEVILACQUA, G, TROCK, B, LIPPMAN, M. E, CULLEN, K. J

    Published in Journal of endocrinological investigation (01-03-1998)
    “…In breast cancer, insulin-like growth factor II (IGF-II) is stromal in origin and is considered an important regulator of tumour epithelium growth. The…”
    Get full text
    Journal Article
  19. 19

    Interference of thyroperoxidase on immuno-cytochemical determination of steroid receptors in thyroid tissue by GIANI, C, CAMPANI, D, DE NEGRI, F, MARTINI, L, FABBRI, R, BONACCI, R, CIANCIA, E. M, GIGLIOTTI, A, FIERABRACCI, P, PINCHERA, A

    “…The presence of sexual steroid receptor proteins in thyroid tissue has been previously demonstrated by biochemical means. The aim of this study was to…”
    Get full text
    Journal Article
  20. 20